Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-07-10

Clinical Trial Update: Efficacy, Safety, and Tolerability of Cenicriviroc (CVC) in Combination With Truvada or Sustiva Plus Truvada in HIV 1-infected, Antiretroviral Treatment-naïve, Adult Patients Infected With Only CCR5-tropic Virus [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating cenicriviroc in combination with Truvada or Sustiva plus Truvada for antiretroviral-naïve adults with CCR5-tropic HIV-1 infection; resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cenicriviroc (cenicriviroc)
  • Sustiva (efavirenz)
  • TRUVADA (EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE)

Snippet

Sponsor: Tobira Therapeutics, Inc. | Conditions: HIV-1 Infection | Phase 2 | Status: COMPLETED